The problem of the quiescent cancer cell

Advances in Enzyme Regulation

Volumn 29, Issue C, 1989, Pages 27-46

  Jackson, Robert C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; RNA;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL LINE; COMPUTER SIMULATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; DRUG RESISTANCE; HUMAN; KINETICS; PHYSIOLOGY;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE; COMPUTER SIMULATION; CULTURE MEDIA; DNA, NEOPLASM; DRUG RESISTANCE; HUMAN; KINETICS; MODELS, BIOLOGICAL; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0024848568     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0065-2571(89)90092-7     Document Type: Article

References (25)

1. Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells
2. Resistance to adriamycin in multicellular spheroids
3. Distribution and activity of antineoplastic drugs in a tumor model
4. In quest of the quaint quiescent cells
5. Evidence for the recruitment of noncycling clonogenic tumor cells
6. Murine mammary cells in vitro. II. Recruitment of quiescent cells
7. Growth factors, oncogenes and inositol lipids
8. Proliferation-dependent cytotoxicity of anticancer agents: a review
9. Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro
10. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by a metabolite of the anticancer nucleoside, 4-amino-8-(β-d-ribofuranosylaminopyrimido-[5,4-d]pyrimidine
11. Enzyme pattern-directed chemotherapy. Effects of antipyrimidine combinations on the ribonucleotide content of hepatomas
12. Regrowth and radiation sensitivity of quiescent cells isolated from EMT6/Ro-fed plateau monolayers
13. Mechanism of resistance of noncycling mammalian cells to 4′(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism and DNA breakage in log and plateau phase Chinese hamster fibroblast cell cultures
14. Computer models of anticancer drug interaction
15. Kinetic simulation of anticancer drug interactions
16. Simulation in cancer research
17. Computer simulation in the service of chemotherapy
18. The role of ribonucleotide reductase in regulation of the deoxyribonucleoside triphosphate pool composition: studies with a kinetic model
19. Chemical control of cancer
20. The influence of tumor growth kinetics on the response to radiation therapy and drug therapy in man
21. Increased cytotoxicity and therapeutic activity of 2′,2′-difluorodeoxycytidine over cytosine arabinoside in L1210 leukemia
22. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes
23. Erythrocytes adenosine triphosphate and deoxyadenosine triphosphate measurements predict toxicity following 2′-deoxycoformycin therapy
24. Deoxyadenosine toxicity to human peripheral blood lymphocytes: implications for 2′-deoxycoformycin as a potential immunosuppressive drug
25. Inhibition of transcription as a mechanism of lymphocytotoxicity induced by adenosine and 2′-deoxycoformycin